Halifax, Canada

F Jon Geske


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Westminster, CO (US) (2010)
  • Halifax, CA (2012)
  • Broomfield, CO (US) (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: F Jon Geske: Innovator in Thromboxane A2 Detection

Introduction

F Jon Geske is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the detection of thromboxane A2 metabolites. With a total of 3 patents to his name, his work has the potential to enhance the understanding of aspirin's anti-thrombotic effectiveness.

Latest Patents

One of Geske's latest patents focuses on methods and kits for the detection of thromboxane A2 metabolites. This invention provides methods, compositions, and kits for measuring the effectiveness of aspirin in preventing thrombotic events in subjects. The patent includes a novel assay designed to quickly and specifically measure TxA2 metabolite levels in urine, correlating these levels with the aspirin dose administered to a subject. The methods utilize a unique anti-TxA2 metabolite antibody, which enhances the accuracy of the measurements.

Career Highlights

Throughout his career, F Jon Geske has worked with reputable organizations such as Corgenix Medical Corporation and Cayman Chemical Company Incorporated. His experience in these companies has contributed to his expertise in the field of medical diagnostics and innovation.

Collaborations

Geske has collaborated with professionals like Amy Whittier and Daniel Tew, further enriching his work and expanding the impact of his inventions.

Conclusion

F Jon Geske's contributions to the detection of thromboxane A2 metabolites represent a significant advancement in medical diagnostics. His innovative methods and collaborations continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…